Embeda and Device occlusion - a phase IV clinical study of FDA data

Summary:

We study 14,714 people who take Embeda (morphine sulfate; naltrexone hydrochloride) or have Device occlusion. No report of Device occlusion is found in people who take Embeda.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Embeda?

Embeda has active ingredients of morphine sulfate; naltrexone hydrochloride. eHealthMe is studying from 1,407 Embeda users. Check the latest studies of Embeda.

What is Device Occlusion?

Device occlusion is found to be associated with 591 drugs and 512 conditions by eHealthMe. Check the latest studies of Device occlusion.

On Jun, 18, 2026

No report is found.

Do you take Embeda and have Device occlusion?

- Check whether Device occlusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Embeda:

Embeda (1,407 reports)

Device occlusion treatments and more:

Device occlusion (13,307 reports)

How severe was Device occlusion and when was it recovered:

Device occlusion in Embeda

Expand to all the drugs that have ingredients of morphine sulfate; naltrexone hydrochloride:

Device occlusion and drugs with ingredients of morphine sulfate; naltrexone hydrochloride

Browse all side effects of Embeda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Device occlusion:

Device occlusion

Browse all the conditions that are associated with Device occlusion:

Device occlusion

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate; naltrexone hydrochloride (the active ingredients of Embeda) and Embeda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.